HCW Biologics Inc.

NASDAQ: HCWB · Real-Time Price · USD
3.57
-0.45 (-11.19%)
At close: Aug 19, 2025, 3:59 PM
3.16
-11.49%
After-hours: Aug 19, 2025, 07:56 PM EDT

HCW Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.67M 3.6M 22.33M 11.73M
Short-Term Investments
n/a n/a 9.74M 24.98M
Long-Term Investments
1.6M 1.6M 1.6M 11.52M
Other Long-Term Assets
28.48K 56.54K 333.88K 393.32K
Receivables
582.2K 1.54M 417.69K 133K
Inventory
n/a n/a 1.39M 2.2M
Other Current Assets
113.53K 230.92K 196.01K 1.44M
Total Current Assets
5.7M 6.4M 34.07M 40.48M
Property-Plant & Equipment
22.91M 20.45M 10.8M 1.12M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
24.54M 22.11M 12.74M 13.03M
Total Assets
30.24M 28.51M 46.81M 53.51M
Account Payables
22.33M 6.17M 1.23M 223.66K
Deferred Revenue
n/a n/a n/a 1.8M
Short-Term Debt
6.31M n/a n/a n/a
Other Current Liabilities
774.94K n/a n/a n/a
Total Current Liabilities
29.63M 8.75M 2.96M 2.32M
Long-Term Debt
7.38M 6.3M 6.41M n/a
Other Long-Term Liabilities
n/a n/a 14.28K n/a
Total Long-Term Liabilities
7.38M 6.3M 6.42M n/a
Total Liabilities
37.01M 15.05M 9.38M 2.32M
Total Debt
13.69M 6.3M 6.41M n/a
Common Stock
4.45K 3.6K 3.59K 3.58K
Retained Earnings
-100.56M -70.53M -45.54M -30.64M
Comprehensive Income
n/a n/a n/a -53.51M
Shareholders Equity
-6.77M 13.46M 37.43M 51.19M
Total Investments
1.6M 1.6M 11.34M 36.51M